Leerink Partners analyst Mike Kratky maintained a Buy rating on Tandem Diabetes Care (TNDM – Research Report) on November 25 and set a price ...

Tandem's sales growth has failed to translate to shareholder wealth for several reasons. Click here to read why TNDM stock is ...

Embecta announced today that it discontinued its insulin patch pump program and plans to initiate a restructuring plan.

We recently compiled a list of the 10 Oversold Healthcare Stocks To Invest In. In this article, we are going to take a look ...